H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.1% of adults in Garden Grove have diagnosed diabetes — 2.1 points above the U.S. 12% figure. Census population 172,646. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Garden Grove clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Garden Grove storefront.
361 HCT/P Compliant Tissue Products in Garden Grove, CA for clinics & physicians. Exclusively 361 HCT/P co… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of 361 hctp compliant products in Garden Grove: (1) CDC PLACES (2023, crude) estimates 14.1% of adults in Garden Grove have diagnosed diabetes — 2.1 points above the U.S. 12% figure. (2) California Part B wound biologics are reviewed by Noridian Healthcare Solutions under JE, shared with HI, NV. We help with the second file. We do not pretend to be a Garden Grove storefront.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)California shares JE with HI, NV. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 14.1% of adults in Garden Grove have diagnosed diabetes — 2.1 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Garden Grove trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 14.1% of adults in Garden Grove have diagnosed diabetes — 2.1 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 14.1% of adults — 2.1 points above the U.S. 12% figure. Obesity is 23.1%; arthritis is 17.9%. That is place-level BRFSS modeling, not a clinic census and not a Garden Grove trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Garden Grove clinic. Ask for the bank’s registration and AATB status on the SKU you want.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.1% diabetes and 17.9% arthritis for Garden Grove — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Garden Grove, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Garden Grove is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Garden Grove — 2.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Garden Grove. Useful for joint-program math; still needs a diagnosis and privileging.
No Garden Grove storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.